Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.64 - $1.03 $2,148 - $3,457
-3,357 Reduced 0.97%
341,574 $276,000
Q1 2023

May 15, 2023

SELL
$0.46 - $0.77 $40 - $66
-87 Reduced 0.03%
344,931 $241,000
Q4 2022

Feb 08, 2023

SELL
$0.51 - $17.1 $1,413 - $47,384
-2,771 Reduced 0.8%
345,018 $244,000
Q3 2022

Nov 14, 2022

SELL
$1.01 - $17.0 $60 - $1,020
-60 Reduced 0.02%
347,789 $529,000
Q2 2022

Aug 02, 2022

BUY
$0.54 - $1.41 $86,327 - $225,409
159,865 Added 85.04%
347,849 $345,000
Q1 2022

Apr 28, 2022

BUY
$1.4 - $5.15 $28,219 - $103,808
20,157 Added 12.01%
187,984 $271,000
Q4 2021

Feb 15, 2022

SELL
$4.27 - $6.97 $96,292 - $157,180
-22,551 Reduced 11.85%
167,827 $876,000
Q3 2021

Nov 15, 2021

SELL
$5.31 - $8.25 $39,309 - $61,074
-7,403 Reduced 3.74%
190,378 $1.11 Million
Q2 2021

Aug 09, 2021

SELL
$6.81 - $9.23 $490 - $664
-72 Reduced 0.04%
197,781 $1.59 Million
Q1 2021

May 14, 2021

SELL
$7.99 - $15.0 $93,842 - $176,175
-11,745 Reduced 5.6%
197,853 $1.65 Million
Q4 2020

Feb 16, 2021

SELL
$7.04 - $11.7 $492 - $819
-70 Reduced 0.03%
209,598 $1.59 Million
Q3 2020

Nov 13, 2020

SELL
$9.98 - $18.04 $698 - $1,262
-70 Reduced 0.03%
209,668 $2.24 Million
Q3 2020

Nov 13, 2020

BUY
$9.98 - $18.04 $299 - $541
30 Added 0.01%
209,738 $1.75 Million
Q2 2020

Jul 20, 2020

SELL
$7.49 - $15.16 $224 - $454
-30 Reduced 0.01%
209,708 $3.18 Million
Q1 2020

Jul 20, 2020

SELL
$4.62 - $18.74 $285,405 - $1.16 Million
-61,776 Reduced 22.75%
209,738 $1.75 Million
Q4 2019

Feb 18, 2020

SELL
$14.6 - $18.13 $13,110 - $16,280
-898 Reduced 0.33%
271,514 $4.59 Million
Q3 2019

Jan 16, 2020

SELL
$16.62 - $23.92 $781 - $1,124
-47 Reduced 0.02%
272,412 $5.06 Million
Q2 2019

Nov 22, 2019

SELL
$17.79 - $22.88 $800 - $1,029
-45 Reduced 0.02%
272,459 $0
Q1 2019

Jun 11, 2019

BUY
$11.76 - $22.15 $3.2 Million - $6.04 Million
272,504 New
272,504 $5.73 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.